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Human  bartonellosis, known as Carrion's disease, manifests itself in two distinct 
phases.  The  first phase,  Oroya fever, is a  severe hemolytic anemia,  the  result of 
the invasion of the blood stream by the organism, Bartonella bacilliformls.  Blood 
cultures are strongly positive at this stage of the disease; and the red blood cells, as 
well as the cells of the reticulo-endothelial system, are heavily parasitized by Barto- 
nella.  The  second phase,  veurrga peruana,  is characterized by the  appearance of 
the typical cutaneous eruption, from the nodules of which B. bacilliformis may be 
recovered.  BartoneUosis is endemic in certain regions of Peru, and has more recently 
been found to be so in Colombia and Ecuador.  In these endemic regions, the second 
stage (verruga) is more commonly encountered.  Less frequently, the anemic stage, 
when  very severe,  ends  fatally before the  development of  the  eruption.  A  large 
percentage of the native population of the endemic zones in Peru have had some form 
of bartonellosis, mild or severe, and are able to  live there  without further clinical 
evidence of infection.  Second attacks of acute fever without  the eruption are ap- 
parently unusual; but second attacks of verruga with minimal febrile illness are not 
rare.  From these facts,  it is evident that  in most of  those individuals who  have 
contracted bartonellosis at least once, a  definite and long lasting immunity develops 
against the infection.  This immunity on the part of the natives is in strong contrast 
to  the  often  fatal infection which develops in  individuals from non-endemic zones 
who spend but a few nights in the endemic zones without adequate protection against 
the night fying sandfly vector.  Somewhere in between these two extremes of com- 
plete immunity on  the one hand,  and  complete susceptibility on  the other,  if one 
* The writer wishes gratefully to acknowledge the hospitality of Dr. T. S. Battistini, 
the Director, and his colleagues, of the Institute of Hygiene and Public Health in 
Lima, Peru, where this work was started in collaboration with Messrs. C. H. Plimpton 
and  B.  Eiseman  of  the  Harvard  Medical School.  His  sincere  thanks  are  due  to 
Dr.  M.  Hertig for counsel and assistance given in  the field and in the laboratory. 
In  the  Schools of  Medicine and  Public Health  of Harvard  University, the  writer 
is indebted to Dr. Q. M.  Geiman for encouragement, and generosity in allowing the 
use of new methods of cultivation recently devised by him; to Dr. A. W. Sellards for 
the hospitality of his laboratory; and to  Mr. B. L. Bennett for material assistance 
expertly rendered. 
65 66  AGGLUTININS FOR BARTONELLA BACILLIFORMIS 
speculates in terms of immunology, must lie the so called carriers, thought by Weinman 
and Pinkerton (1) to represent a possible reservoir of infection.  These authors have 
estimated the number of such individuals in one locality of the endemic region  of 
Peru at about 5 to 10 per cent of the total population.  They show no outward sign 
of infection; but B. bacilliformis may be recovered from their blood,  which  may or 
may not show  a  slight anemia.  It is evident from the foregoing  rather empirical 
facts that  the fundamental immunological  pattern  of human  bartonellosis  remains 
still  to  be worked out.  The present  report is  a  step  toward  the  solution  of this 
complex  problem. 
The work which  follows deals with the production  and the demonstration 
of specific agglutinins for B. bacilliformis  in rabbits, and their demonstration 
in the sera of human beings with bartonellosis.  In the literature on Carrion's 
disease,  the  possibility of agglutinating  B.  bacilliformis  with  specific sera of 
one sort or another has been considered from time to time by various authors 
(2-7).  In no instance is there any indication of clear-cut experiments on this 
aspect of the problem; and in all cases the only tangible conclusion that has 
been reached is that any demonstration of agglutinins is handicapped by the 
difficulties encountered in preparing suspensions of the organism suitable for 
use as an antigen. 
Materials  and  Methods 
Media and Cultivation  of Bartonella.--Heretofore,  the only media that have 
yielded  fairly  satisfactory  growth  have  been  ordinary  blood  agar  and  the 
semisolid medium of Noguchi and  Battistini  (3)  originally designed  for the 
cultivation of Leptospira.  The former medium yields colonies of tightly packed 
organisms on the slant, with many of the colonies embedded in agar; the latter 
medium a  variable  and  diffuse  growth,  with  aggregates  of smaller  satellite 
granules, in the upper I to 2 cm. of the medium.  Both types of medium present 
obstacles to the preparation of a  homogeneous suspension, chief among which 
is that resulting from the presence of agar, from which the organisms are in- 
separable.  Two types of medium recently developed by Geiman in Boston 
(8)  have effectively removed these obstacles. 
The first is a solid medium.  Special base agar is made with 2 per cent shredded 
agar, 2 per cent tryptone or proteose peptone, 0.5 per cent sodium chloride, in distilled 
water.  The medium, as finally used, is composed of 75 per cent base agar, adjusted 
to pH 7.6-7.8  and cooled to 45°C.; and 25 per cent fresh rabbit or sheep serum, or 
defibrinated whole blood.  To the whole medium, a  small amount  (0.2 per cent of 
the total volume of medium) of an ascorbic acid-glutathione solution is added.  This 
medium gives a profuse growth, which follows the streak of the loop on the slant and 
becomes  grossly visible in  24  to 48 hours,  reaching a  maximum in  10 to  14 days. 
The optimal temperature for incubation is 28°C.  The growth may be easily scraped 
from the  surface,  and  collected  from the  water of condensation  at  the  bottom of 
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The second is a  liquid medium.  It  is  composed of  three parts  of  a  1 per  cent 
solution of tryptone adjusted to pH 7.6-7.8, to one part fresh rabbit serum; and to 
the  whole  medium is added  a  small amount  (0.2 per  cent of  the  total volume of 
medium)  of  the  ascorbic acid-glutathione solution.  Growth  becomes visible as  a 
finely divided sediment within 24 to 48 hours, and reaches a peak on the 10th day, 
when incubated at 28°C.  It has been found by Geiman that maximum growth takes 
place at the bottom of the container when the depth of this medium is from 0.5 to 
0.75  cm.  Small (50 cc.)  Erlenmeyer flasks  are  used,  to  afford  as large an area as 
possible, at this optimal depth, for the growth which takes place on the bottom of the 
flask.  The present writer has found that ordinary test tubes (14 cm.  X 2 cm.), bent 
to resemble a hockey stick in shape, with the short arm at the open end of the tube, 
serve better than Erlenmeyer flasks for the cultivation of Bartonella.  The tubes are 
stored horizontally, the open end directed upward, to prevent outflow of the medium 
with which the tubes are filled to half of their horizontal depth, i.e. 0.5 to 0.75 cm. 
Growth takes place along the  bottom of  the  converted test  tube, and the yield is 
about equal to that obtained with the flasks.  There is further the added advantage 
of  convenience; and less  danger of  contamination than that  encountered with the 
flasks. 
Preparation of Antigen.--The  organisms harvested  from both  types of  medium, 
when washed two or three times in normal saline, and resuspended in saline buffered 
to pH 8.2-8.4, constitute a homogeneous antigen admirably suited for agglutination 
tests.  It  has  been found more  recently that  clumps of  organisms harvested  in a 
similar manner, but stored as a  coarse  suspension in normal unbuffered saline can, 
after about a week of such storage, be easily emulsified by churning with a capillary 
pipette, (9).  The coarser particles in either type of suspension are allowed to settle 
or are thrown down by slow centrifugation.  In both cases,  dark field examination 
reveals a  fairly regular distribution of  single organisms, with occasional clumps of 
never more than 5 to  10  (Fig.  1).  These occasional clumps are just visible with a 
10 or 14 power hand lens. 
Technique of Agglutination  Test.--The  technique of  the  test  for agglutinins has 
been designed to  allow  rigid economy of  materials, and at  the  same  time permit 
accurate gradation of titre.  Small fermentation tubes (7.5 cm. X 0.75 cm.) are used; 
and the total final volume confined to about 0.1  cc.  The tubes, after proper serial 
dilution of the sera and the addition of the antigen, are incubated for 4 to 6 hours at 
40°C. and are then read with the aid of a  10-14  )<  hand lens; and after 24 hours on 
ice they are again read.  In the strongly positive tubes, there is a heavy and tightly 
coherent precipitate with clear supernatant liquid.  Dark field examination (Fig.  2) 
reveals a  definite heavy clumping of  the  single organisms and the  small groups of 
organisms seen in the control (Fig. 1).  In the negative and the control tubes, when 
examined with the hand lens, there is never more than a very slight sediment, which is 
easily dispersed. 
Immunization  of Rabbits.--To  obtain specific agglutinins, a  series  of  rabbits was 
immunized by repeated  injections of  living B.  bacilliformis into the marginal vein 
of the ear.  The organisms from a  tube of liquid culture, after 10 days to 2 weeks 
incubation, or a week's growth from a solid slant, washed twice with saline, was given 
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FIG. 1.  Suspension of Bartonella  bacilliformis in normal saline.  Dark field photo- 
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I~'IG. 2.  Agglutination  of BartoneIla bacilliformis by serum of immunized rabbit 1 in 
dilution of 1:640.  Dark field photomicrograph.  X  about 4000, oil immersion. 70  AGGLUTININS  FOR  BARTONELLA  BACILLIFORMIS 
tions in all at the end of that time.  Two rabbits were treated in a manner different 
from the others.  One of these (rabbit 1) was inoculated every 3rd or 4th day with the 
material and by the method described above, 15 inoculations having been given at the 
end of 50 days.  The other rabbit  (rabbit 2)  had been splenectomized, and into the 
anterior  chamber of both  eyes,  chopped  rabbit  embryo had  been  successfully im- 
planted.  B. bacilliformis was then injected into both anterior chambers, and given 
in large quantity intratracheally, in an attempt to produce some tangible evidence of 
pathogenic effect.  2 weeks after the intratracheal and intraocular inoculations, one 
eye, which was then aseptically removed, showed a marked pannus formation, with 
ingrowth of vessels  into  the  cornea; and  the other eye showed nothing.  Cultures 
taken from the implanted tissue and the aqueous humor of the enucleated eye showed 
a  heavy growth of B.  bacilliformis; but  blood cultures  were  negative.  Serum  for 
agglutination was taken at this time.  At no time did any of the animals, no matter 
in  what way they had  been inoculated,  show any signs  of systemic reaction  which 
could have been interpreted as having resulted from the inoculation. 
Results  with  Rabbit  Sera 
The results obtained  in testing the  sera  of these rabbits  for agglutinins  by 
the  method described are shown in Table  I.  In the  case of rabbits  1 and 3, 
in order to determine  the rate at which antibodies might be appearing,  serum 
was taken after  one-half the total projected number of inoculations had been 
given; and  showed a  moderate  titre  of agglutinins.  The titre  as determined 
after  all  inoculations had been given was proportionately higher  in all  cases. 
The definitely higher  titre  of rabbit  1 as compared with  that of rabbits  3, 4, 
and 5 might be explained by the larger number of inoculations given at shorter 
intervals to rabbit  1 (15 inoculations in 50 days as opposed to 12 in 60 days); 
although  this  difference in  titre  may only be an indication  of wide variation 
in  the  strength  of  response  among  individual  animals.  There  was  in  the 
case of rabbits  1,  3, and 4 a  marked falling-off of titre at the end of 1 month 
after  the  last  inoculation.  Rabbit  5  showed a  somewhat  higher  titre  of ag- 
glutinins than did the other two, and maintained  this higher titre longer than 
the latter,  although there  was a  slight but definite  falling-off at the end of 1 
month after the last inoculation.  In the case of rabbit 2 the titre of agglutinins 
obtained as a  result of the simultaneous intraocular and intratracheal  inocula- 
tions described above, lies midway between that of rabbit 1 and those of rabbits 
3 and 4.  There is no indication, in this single experiment (rabbit 2), as to which 
method of inoculation may have resulted in so high a titre, or whether both were 
necessary to produce it.  The fact that cultures made from the eye fluid and the 
infected implanted  embryonic tissue were strongly positive after  2 weeks sug- 
gests the possibility that these two foci were a source of continuous stimulation 
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Results  with  Human  Sera 
Table II summarizes the findings with a  small group of human sera.  Two 
cases in which the anemic manifestation had been minimal and the verrucous 
TABLE I 
Agglutination of Bartondla bavilliformis by Serum of Immunized Rabbits 
Rabbit 
--I 
Time 
Before immunization 
Mter 7 intravenous inoculations in 22 
days 
5 days after last of 15 intravenous inocu- 
lations given over 50 days 
28 days after last intravenous inoculation 
Before intratracheal and intraocular  in- 
oculation 
13 days after intratracheal and intraocu- 
lar inoculation 
34 days after intratracheal  and intraocu- 
lar inoculation 
Before immunization 
Mter  7 intravenous  inoculations  in  33 
days 
3 days after last of 13 intravenous inocu- 
lations given over 60 days 
36 days after last intravenous inoculation 
Before immunization 
5 days after last of 12 intravenous inocu- 
lations given over 60 days 
37 days after last intravenous inoculation 
Before immunization 
3 days after last of 13 intravenous inocu- 
lations given over 64 days 
36 days after last intravenous inoculation 
Final dilution of serum 
1:10  1:20  1:40  1:80  1:160  1:320  1:640 
4+  4+  4+  4+  2+  --  -- 
4+  4+  4+  4+  4+  4+  3+ 
4+  4+  4+  3+  2+  --  -- 
4+  4+  3+  3+  +,  --  -- 
4+  4+  4+  4+  3+  3+  -- 
2+  2+  2+  +  +  - 
4+  4+  4+  3+  2+  - 
4+  4+  4+  +  -  - 
4+  4+  3+  2+  2+  + 
3+  3+  3+  +  --  - 
3+  3+  3+  3+  2+  2+ 
3+  3+  3+  2+  2+  2+ 
4+, heavy coarse precipitate at bottom of tube; clear supernatant liquid. 
3+ to +, gradually  decreasing amounts  of precipitate,  but obvious agglutination  of sus- 
pended organisms when compared with saline and normal serum controls. 
--, no agglutination. 
stage more extensive (cases  1 and  5)  showed the highest titre of agglutinins; 
and the two severe cases of Oroya fever (cases 2 and 3)  the lowest.  Thirteen 
normal human sera were consistently and entirely negative.  Although definite 72  AGGLUTININS  :FOR  BARTO~TELLA  BACILLIFOI~MIS 
conclusions cannot be drawn  from so small a  series of cases,  the possibility 
that the appearance of the eruption is associated with the formation of a demon- 
strable titre of circulating antibodies may be considered.  The development of 
the  eruption is invariably regarded by experienced clinicians as a  favorable 
prognostic sign.  The fact that the serum of the so called "immune" (case 6) 
contained a  minimal titre of agglutinins  may be analogous to the falling-off 
of titre noted with the rabbit sera.  A satisfactory test for the virulence of the 
organism  concerned  (and  hence  a  susceptible  laboratory animal)  would,  of 
course, be necessary in the final elucidation of the fundamental immunological 
process involved in human bartoneUosis. 
TABLE II 
Agg4ulgnalion of Bartonella baciUiformis with Sera of Patients Suffering  or Recovered  from 
Bartonellosis (Carrion'  s Disease) 
Case 
Normal human 
serum* ........ 
Final dilution of serum 
1:10 
2+ 
+ 
+ 
+ 
2+ 
+ 
1:20 
+ 
+ 
4- 
+ 
+ 
1:40 
+ 
+ 
1:80 
± 
-4- 
* Thirteen  normal human  sera were tested. 
4+, heavy coarse precipitate at bottom of tube; clear supematant liquid. 
3+  to +, decreasing amounts of precipitate at bottom of tube; but obvious agglutination 
of suspended organisms when compared with saline and normal serum controls. 
-4-, slight but definite agglutination, with no heavy precipitate. 
--, no precipitate or agglutination. 
The question of the relationship of Bartondla to the organisms of the Rickett- 
sia group  has  also been  explored.  With  this possible  connection in  view, 
the six human sera tested for agglutinins for Bartvndla were also tested with 
three strains  of t~roteus,  after the manner of the  Weil-Felix reaction.  The 
results  are  shown  in  Table  III.  The  two  sera  which  agglutinated  Bar- 
tondla  most  strongly also  show  the  highest  titres with  two  of the  Proteus 
strains (sera of cases 1 and  5).  Although a positive agglutination at a  dilu- 
tion higher  than  1:50  is  usually  considered significant with  the  Weil-Felix 
reaction,  there  are  occasional  cases  without  a  positive  history  of  typhus 
whose sera are positive in much higher dilutions.  Since,  also,  the histories 
of the cases involved herein had not been probed for the possibility of typhus, CALDERON  HOWE  73 
no definite conclusions can  be drawn as  to  the  meaning of the  results  ob- 
tained with these particular sera.  The question becomes even more obscure 
from lack of knowledge of the  distribution of endemic typhus fever in Peru. 
The only available figure is  that of the total number of cases during the year 
TABLE III 
Agglutination of Proteus OX19, OXK, and OX2 
Case 
Normal hu- 
man  serum 
SUa~ 
Final dilution of serum 
1:8  1:16  1:32  1:64 
Proteus OX19  4+  4+  4+  3+ 
Proteus OXK  3+  2+  2+  -- 
Proteus OX2  4+  4+  2+  + 
Proteus OX19  3+  2+  2+  + 
Proteus OXK  2  +  --  --  -- 
Proteus OX2  3+  2+  +  + 
Proteus OX19  4+  3+  2+  + 
Proteus OXK  3+  2+  +  -- 
Proteus OX2  4+  3+  +  -- 
1:128 
2+ 
m 
m 
Proteus OX19  2+  +  --  --  -- 
Proteus OXK  4+  3+  +  --  -- 
Proteus OX2  2+  .... 
Proteus OXI9  4+  4+  3+  3+  + 
Proteus OXK  4+  4+  2+  +  -- 
Proteus OX2  4+  4+  3+  2+  + 
Proteus OX19  .... 
Proteus OXK  3+  2+  2+  -- 
Proteus OX2  +  --  --  -- 
Proteus OX19  3+  +  --  --  I 
Proteus OXK  3+  2+  --  I  Proteus OX2  3+  2+  + 
1:256 
+ 
m 
m 
m 
m 
m 
m 
m 
m 
R 
B 
m 
m 
All saline controls negative.  Bar~ondla-immune  rabbit serum negative with all strains of 
Proteus. 
Tubes incubated 4 hours at 40°C. 
Legend the same as that for Tables I and II. 
1940, January through  September, amounting to 667, no geographical alloca- 
tion being given in the report (10).  It  is of importance to note, from an im- 
munological point  of  view,  that  there  was  no  agglutination of  Proteus  in 
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Origin of the Human Sera Represented in Tables H  and III, with a Brief Description of 
Each Case 
Case 1.--Serum was taken during the 3rd month of a  third mild attack of barto- 
neUosis,  at  which  time  there  was  slight  anemia,  and  extensive  eruption.  Blood 
cultures were negative, having been positive during the 1st month of the recurring 
disease,  during which time there had been no eruption. 
Case 2.--Serum was taken on the 12th day of the disease.  There was severe anemia 
(red blood cell count 1.7 million); blood cultures were positive; and Bartonella were 
found in the blood film.  Death occurred on the 15th day of the disease. 
Case &--Serum was taken on the 16th day of the disease.  There was severe anemia 
(red blood cell count 1.0 million); blood cultures were positive; and Bartonella were 
found in the blood film.  There was subsequent recovery, no Bartonella having been 
found in the blood films after the 26th day, at which time blood cultures also became 
negative. 
Case 4.--Serum  was  taken  during  the  2nd  month  of a  mild  attack  of verruga 
peruana,  the  eruption  having appeared  after  1 month  of symptoms.  Laboratory 
data were not available, and the history not precisely known.  The eruption, however, 
was definitely that of verruga, but was confined to one large "mulaire" type of lesion 
on the left shin. 
Case 5.--Serum was taken during the 2nd month of an attack of verruga peruana. 
The appearance of the rash was preceded by symptoms of malaise and joint pains. 
Laboratory  data  were  not  available,  and  the  history  not  precisely  known.  The 
eruption, however, was definitely that of verruga, and was far more extensive than 
that of case 4. 
Case 6.--This was a  so called "immune," who, having had verruga in childhood, 
has remained  free from signs and  symptoms of bartonellosis  all of his life  (30-odd 
years) in spite of frequent and prolonged sojourns in the areas where Oroya fever and 
verruga peruana are endemic. 
DISCUSSION 
The  fact  that  it  is  possible  to  produce  circulating  antibodies  in  rabbits, 
and  that  circulating antibodies  may be  demonstrated  in human  beings  with 
bartoneUosis makes it certain that at some stage during the course of an infec- 
tion with B. bacilliformis there is a  measurable immunological response on the 
part of the host.  This response, now proven by the formation of agglutinins, 
can be used as a basis for further investigation with three principal objectives: 
1)  A  clarification  of  the  fundamental  immunological  sequence  in  human 
bartonellosis; 2) an evaluation of the properties of immune sera in the therapy 
of Oroya fever and of the effectiveness of vaccines in the prophylaxis of non- 
immune individuals; and 3) an elucidation of the antigenic and immunological 
characteristics  of B.  bacilliformis.  With  regard  to  the  latter  problem,  pre- 
liminary  studies  have  already  been  undertaken  to  determine  possible  im- 
munological variations  among Bartonella  isolated  from different  sources and 
localities.  These  experiments  have  indicated  that  no  immunological  differ- CALDERON HOWE  75 
ences between such  strains can be  demonstrated by the agglutination test, 
cross-agglutination between  four  Peruvian  and  two  Colombian  strains  by 
homologous and heterologous sera to almost equal titre having been accom- 
plished. 
1.  Methods of preparing a  satisfactory antigen having been developed, a 
technique for performing an agglutination test with B. bacilliformis  is made 
available. 
2.  As  a  result  of repeated  intravenous injection of living cultures  of  B. 
bacilliformis at short intervals, rabbits have been found to produce a high titre 
of specific  agglutinins which,  under the conditions obtaining in the present 
series of experiments, begins to decline after about one month following the 
last inoculation. 
3.  Sera from six cases of bartonellosis in different stages of its several mani- 
festations have been shown by the agglutination test to  contain a  low but 
definite titre  of circulating antibody. 
4.  Several of these  same sera  have been shown to  contain as well a  sig- 
nificantly high titre  of agglutinins for three  strains  of Proteus.  No definite 
conclusions can be drawn from this phenomenon since the case histories had 
not been probed for the possibility of typhus fever; and since the relatively high 
titres obtained with a  few of the present sera may very well fall within the 
extremes of normal serum titres. 
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